1. Increasing government oversight. David Kwiat, MD, an ophthalmologist and part-owner of Fulton County Ambulatory Surgery Center in Johnstown, N.Y., predicts that ASCs will be additionally pressed for resources due to additional governmental control and oversight coupled with decreasing reimbursements.…
Uncategorized
If health reforms are not enacted, there will be higher numbers of uninsured, an erosion of employer-sponsored coverage, increased spending on public programs and big increases in out-of-pocket insurance costs, according to a report by the Urban Institute.
Surgical Care Affiliates has entered into a joint-venture agreement with Lakeside Surgery Center in Glendale, Calif., according to an SCA press release.
Responding to President Obama's challenge to Republicans, "If you have a better idea, show it to me," Former House Speaker Newt Gingrich and John Goodman, president and CEO of the National Center for Policy Analysis came up with 10 of…
CHICAGO — Becker's Orthopedic & Spine Review has announced "50 of the Best Spine Specialists in America," profiling top spine surgeons, physicians and innovators in the country.
The Food and Drug Administration may toughen is approval process for 510(k) clearance for medical devices, according to a report by the Wall Street Journal. The move causes concern for medical device makers who worry that tightened approval processes could…
Bay Pines (Fla.) VA Medical Center is constructing a new medical building that will include an ASC and eye treatment center, according to a report by the Seminole Beacon.
Kansas City, Mo.-based Cerner Corp. has announced a record number of bookings in the fourth quarter of 2009, up 68 percent to $680.4 million from fourth quarter 2009. Net revenue for the quarter was $466.3 million and net earnings were…
Cameron J. Justice of Crum, W.Va., owner and president of Justice Medical Complex, with conspiracy to misuse a physicians registration number and aiding and abetting healthcare fraud, according to a report in The Charleston Gazette.
Glaucoma medications were associated with a reduced likelihood of death in U.S. adults with glaucoma, according to a study published in the February issue of the Archives of Ophthalmology.
